Rxi Pharmaceuticals to recruit a new Chief Financial Officer

Download PDF Copy

Reviewed

Aug 21 2009

RXi Pharmaceuticals Corporation (Nasdaq: RXII) today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.

Tod Woolf, Ph.D. President and CEO said, “We would like to thank Steve for his leadership and important contributions as RXi expanded its operations, became a public company in early 2008 and closed subsequent rounds of financing. We wish Steve well in his future endeavors.“

The Company will be recruiting a new Chief Financial Officer.

Source:

http://www.rxipharma.com/

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Largest study of African American brain tissue reveals key Alzheimer gene activity

Innovative approaches target PAR2 receptor to alleviate gut pain

Off-label drug helps one boy with autism speak, parents say. But experts want more data.

New technology improves the efficiency of protein production in E. coli

Menopause symptoms disrupt daily life, but few women get treatment

Clinical Frailty Scale can quickly predict mortality in patients with heart failure

Study highlights need to establish clinical practice guidelines for surgical patients receiving MOUDs

New study offers hope for patients with treatment-resistant focal epilepsy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.